Switch to:
Array BioPharma Inc (NAS:ARRY)
EV/EBITDA
-7.91 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Array BioPharma Inc's enterprise value is $534.9 Mil. Array BioPharma Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $-67.6 Mil. Therefore, Array BioPharma Inc's EV/EBITDA ratio for today is -7.91.

During the past 13 years, the highest EV/EBITDA Ratio of Array BioPharma Inc was 165.90. The lowest was -59.90. And the median was -6.60.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Array BioPharma Inc's stock price is $3.77. Array BioPharma Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $-0.57. Therefore, Array BioPharma Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Array BioPharma Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=534.923/-67.648
=-7.91

Array BioPharma Inc's current Enterprise Value is $534.9 Mil.
Array BioPharma Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was -9.192 (Jun. 2015 ) + -17.858 (Sep. 2015 ) + -21.085 (Dec. 2015 ) + -19.513 (Mar. 2016 ) = $-67.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Array BioPharma Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=3.77/-0.57
=

Array BioPharma Inc's share price for today is $3.77.
Array BioPharma Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was -0.09 (Jun. 2015 ) + -0.15 (Sep. 2015 ) + -0.17 (Dec. 2015 ) + -0.16 (Mar. 2016 ) = $-0.57.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma Inc Annual Data

Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15
ev2ebitda -8.57-7.71-2.12-1.74-2.95-5.58-48.01-11.25-8.3340.89

Array BioPharma Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda -10.75-9.74-8.33-5.60-8.23124.1940.8920.1743.40-6.17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK